Junevity

Junevity is a preclinical-stage biotechnology company that develops siRNA therapeutics to reset gene networks and reverse age-related diseases. Using its RESET platform, which combines AI, ML, and large-scale human genomic data, the company targets transcription factors to treat conditions like Type 2 diabetes and obesity. They operate primarily in the longevity and biotech market, focusing on restoring cellular health to extend human healthspan and lifespan.